Innovotech Inc
Innovotech Inc. provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally. The company offers InnovoSIL, a silver periodate antimicrobial compounds for medical applications; and MBEC Assay kit, a screening assay used to determine the efficacy of antimicrobials against biofilms of a variety of microorganisms; pre-coated MBEC Assa… Read more
Innovotech Inc (IOT) - Total Liabilities
Latest total liabilities as of September 2025: CA$585.33K CAD
Based on the latest financial reports, Innovotech Inc (IOT) has total liabilities worth CA$585.33K CAD as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Innovotech Inc - Total Liabilities Trend (2003–2024)
This chart illustrates how Innovotech Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Innovotech Inc Competitors by Total Liabilities
The table below lists competitors of Innovotech Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Krynica Vitamin SA
WAR:KVT
|
Poland | zł104.22 Million |
|
Masivo Silver Corp
PINK:GNYPF
|
USA | $479.89K |
|
Civil Engineering PCL
BK:CIVIL
|
Thailand | ฿6.61 Billion |
|
Tambourah Metals Ltd
AU:TMB
|
Australia | AU$459.08K |
|
Gelteq Limited Ordinary Shares
NASDAQ:GELS
|
USA | $5.67 Million |
|
Bri-Chem Corp
OTCQB:BRYFF
|
USA | $29.31 Million |
|
FenixOro Gold Corp
PINK:FDVXF
|
USA | $1.31 Million |
|
The Tinley Beverage Company Inc
OTCQB:TNYBF
|
USA | $1.20 Million |
Liability Composition Analysis (2003–2024)
This chart breaks down Innovotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.77 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.21 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.17 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Innovotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Innovotech Inc (2003–2024)
The table below shows the annual total liabilities of Innovotech Inc from 2003 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | CA$596.80K | +173.85% |
| 2023-12-31 | CA$217.93K | +31.84% |
| 2022-12-31 | CA$165.29K | -35.44% |
| 2021-12-31 | CA$256.04K | +44.28% |
| 2020-12-31 | CA$177.46K | +0.38% |
| 2019-12-31 | CA$176.79K | -1.15% |
| 2018-12-31 | CA$178.86K | -48.27% |
| 2017-12-31 | CA$345.76K | -77.60% |
| 2016-12-31 | CA$1.54 Million | +26.95% |
| 2015-12-31 | CA$1.22 Million | +3.53% |
| 2014-12-31 | CA$1.17 Million | +18.33% |
| 2013-12-31 | CA$992.54K | +56454.93% |
| 2003-12-31 | CA$1.75K | -95.64% |
| 2003-09-30 | CA$40.22K | -- |